NCT00668109 - Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia | Biotech Hunter

Enrollment

614

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions

Erectile Dysfunction

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

10 mg one hour prior to sexual intercourse

DRUG

Tadalafil

10 mg taken approximately 24 hours prior to sexual intercourse

Trial Locations (74)

33

Lima

1070

Bruxelles - Brussel

1200

Bruxelles - Brussel

1700

Sarpsborg

2193

Johannesburg

2390

Moelv

2650

Edegem

2940

Newcastle

3200

Pietermaritzburg

3630

Durban

4000

Durban

4091

Durban

6530

George

7006

Trondheim

7505

Cape Town

7800

Cape Town

8800

Roeselare

12004

Castellon

13125

Berlin

13347

Berlin

13465

Berlin

14050

México, D.F.

14080

México, D.F.

15006

A Coruña

20123

Milan

20132

Milan

20142

Milan

20354

Hamburg

26655

Westerstede

27100

Pavia

29010

Málaga

30625

Hanover

31096

Haifa

34000

Durango

35039

Marburg

35128

Padua

36211

Vigo

40000

Iguala de la Independencia

41061

Mönchengladbach

49076

Osnabrück

50009

Zaragoza

52621

Tel Litwinsky

56126

Pisa

64239

Tel Aviv

66260

Monterrey

70372

Stuttgart

79106

Freiburg im Breisgau

80333

München

81925

München

86343

Königsbrunn

90100

Oulu

91120

Jerusalem

92637

Weiden

95124

Catania

Unknown

Barranquilla

Bogotá

Medellín

Santa Fé de Bogotá

00100

Helsinki

00180

Helsinki

06126

Perugia

06700

México, D. F.

7442 LS

Nijverdal

3514 AB

Utrecht

0272

Oslo

CALLAO 2

Callao

LIMA 27

Lima

0083

Pretoria

03550

Sant Joan d'Alacant

08907

L'Hospitalet de Llobregat

07014

Palma de Mallorca

503 32

Borås

541 30

Skövde

171 76

Stockholm